Zhongxing BioTech(SZ:002772) Xin Lang Cai Jing·2026-01-29 03:49Group 1 - The core point of the news is that Zhongxing Junye's stock price dropped by 5% to 15.76 CNY per share, with a trading volume of 162 million CNY and a turnover rate of 2.57%, resulting in a total market capitalization of 6.197 billion CNY [1] - Zhongxing Junye, established on November 18, 2005, and listed on June 26, 2015, is primarily engaged in the research, industrial cultivation, and sales of edible mushrooms [1] - The company's main revenue sources are: 63.04% from Agaricus bisporus, 35.32% from Enoki mushrooms, 0.89% from Cordyceps, 0.53% from ecological breeding of Cordyceps sinensis, and 0.22% from other products [1] Group 2 - Manulife Fund's Manulife Consumer Dividend Index A (008928) is among the top ten circulating shareholders of Zhongxing Junye, having increased its holdings by 363,100 shares to a total of 3.498 million shares, representing 0.9% of the circulating shares [2] - The fund has incurred an estimated floating loss of approximately 2.9033 million CNY today [2] - The fund was established on March 26, 2020, with a current size of 720 million CNY, and has a year-to-date return of 0.21%, ranking 5031 out of 5551 in its category [2] Group 3 - The fund manager of Manulife Consumer Dividend Index A is Li Tingting, who has been in the position for 4 years and 33 days, managing total assets of 2.322 billion CNY [3] - During her tenure, the best fund return was 46.22%, while the worst return was -35.89% [3] Group 4 - In the fourth quarter, Manulife Consumer Dividend Index A reduced its holdings in Zhongxing Junye by 1.269 million shares, bringing the total to 2.229 million shares, which constitutes 2.84% of the fund's net value, making it the fifth-largest holding [4] - The estimated floating loss for the fund today is approximately 1.8501 million CNY [4]